首页> 美国卫生研究院文献>Experimental and Therapeutic Medicine >Effectiveness of continuous veno-venous hemofiltration in the treatment of severe acute pancreatitis
【2h】

Effectiveness of continuous veno-venous hemofiltration in the treatment of severe acute pancreatitis

机译:连续静脉血液滤过治疗严重急性胰腺炎的有效性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Continuous veno-venous hemofiltration (CVVH) in the treatment of severe acute pancreatitis (SAP) was investigated. A total of 60 patients with SAP treated in Affiliated Dongtai Hospital of Nantong University from October 2015 to October 2017 were enrolled in this retrospective study. Among them, 32 patients received CVVH and routine internal medicine therapy (the CVVH group), and 28 received routine internal medicine therapy (the control group). Then biochemical indexes and severity of SAP after treatment were detected to investigate the roles of CVVH and routine internal medicine therapy in treating SAP. Inflammatory factors in both the CVVH and control groups were significantly decreased after treatment (P<0.05), and CVVH could eliminate more factors. Comparison of blood biochemical indexes between the CVVH and control groups were carried out. Significant improvement was found (P<0.05) after CVVH and routine internal medicine therapy. Besides, Acute Physiology and Chronic Health Evaluation (APACHE)-II grade was significantly decreased in the CVVH group compared with that in the control group after 7 days. CVVH therapy can effectively reduce the levels of inflammatory factors in SAP patients, improve their biochemical and physiological indicators, and have high clinical application value.
机译:研究了连续静脉静脉血液滤过(CVVH)在治疗重症急性胰腺炎(SAP)中的作用。这项回顾性研究纳入了2015年10月至2017年10月在南通大学附属东台医院治疗的60例SAP患者。其中,有32例接受了CVVH和常规内科治疗(CVVH组),有28例接受了常规内科治疗(对照组)。然后检测SAP的生化指标和治疗后的严重程度,以研究CVVH和常规内科治疗在SAP治疗中的作用。治疗后CVVH和对照组的炎症因子均显着降低(P <0.05),并且CVVH可以消除更多的因子。比较CVVH组与对照组的血液生化指标。 CVVH和常规内科治疗后有显着改善(P <0.05)。 7天后,CVVH组的急性生理和慢性健康评估(APACHE)-II等级明显低于对照组。 CVVH疗法可以有效降低SAP患者的炎症因子水平,改善其生化和生理指标,具有较高的临床应用价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号